240 related articles for article (PubMed ID: 37143266)
1. Therapeutic Approaches of Dual-targeted Nanomedicines for Tumor Multidrug Resistance.
Han W; Shen Z; Zou J; Ye Q; Ge C; Zhao Y; Wang T; Chen Y
Curr Drug Deliv; 2024; 21(2):155-167. PubMed ID: 37143266
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment.
Mao C; Li F; Zhao Y; Debinski W; Ming X
Theranostics; 2018; 8(22):6274-6290. PubMed ID: 30613297
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance.
Zhou L; Wang H; Li Y
Theranostics; 2018; 8(4):1059-1074. PubMed ID: 29463999
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine therapeutic approaches to overcome cancer drug resistance.
Markman JL; Rekechenetskiy A; Holler E; Ljubimova JY
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1866-79. PubMed ID: 24120656
[TBL] [Abstract][Full Text] [Related]
5. Overcoming multidrug resistance with nanomedicines.
Ganoth A; Merimi KC; Peer D
Expert Opin Drug Deliv; 2015 Feb; 12(2):223-38. PubMed ID: 25224685
[TBL] [Abstract][Full Text] [Related]
6. The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy.
Liu S; Khan AR; Yang X; Dong B; Ji J; Zhai G
J Control Release; 2021 Jul; 335():1-20. PubMed ID: 33991600
[TBL] [Abstract][Full Text] [Related]
7. Novel nanomedicines to overcome cancer multidrug resistance.
Su Z; Dong S; Zhao SC; Liu K; Tan Y; Jiang X; Assaraf YG; Qin B; Chen ZS; Zou C
Drug Resist Updat; 2021 Sep; 58():100777. PubMed ID: 34481195
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
Tekchandani P; Kurmi BD; Paliwal SR
Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
10. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
11. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition.
He Q; Shi J
Adv Mater; 2014 Jan; 26(3):391-411. PubMed ID: 24142549
[TBL] [Abstract][Full Text] [Related]
12. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue.
Gote V; Nookala AR; Bolla PK; Pal D
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925129
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicines for combating multidrug resistance of cancer.
Zhu YX; Jia HR; Duan QY; Wu FG
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1715. PubMed ID: 33860622
[TBL] [Abstract][Full Text] [Related]
14. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
Wei G; Yang G; Wei B; Wang Y; Zhou S
Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
[TBL] [Abstract][Full Text] [Related]
15. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.
Yadav P; Ambudkar SV; Rajendra Prasad N
J Nanobiotechnology; 2022 Sep; 20(1):423. PubMed ID: 36153528
[TBL] [Abstract][Full Text] [Related]
16. Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models.
Petrikaite V; D'Avanzo N; Celia C; Fresta M
Drug Resist Updat; 2023 May; 68():100956. PubMed ID: 36958083
[TBL] [Abstract][Full Text] [Related]
17. Computer-assisted engineering of programmed drug releasing multilayer nanomedicine via indomethacin-mediated ternary complex for therapy against a multidrug resistant tumor.
Che L; Liu Z; Wang D; Xu C; Zhang C; Meng J; Zheng J; Yuan H; Zhao G; Zhou X
Acta Biomater; 2019 Oct; 97():461-473. PubMed ID: 31344512
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicines for Overcoming Cancer Drug Resistance.
Hu T; Gong H; Xu J; Huang Y; Wu F; He Z
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015232
[TBL] [Abstract][Full Text] [Related]
20. Innovative nanochemotherapy for overcoming cancer multidrug resistance.
Tan H; Zhang M; Wang Y; Timashev P; Zhang Y; Zhang S; Liang XJ; Li F
Nanotechnology; 2021 Nov; 33(5):. PubMed ID: 34700307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
